Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 151 - 200 out of 14,060

Document Document Title
WO/2013/189237
Disclosed are a novel andrographolide derivative and analogue as well as a preparation method of the novel andrographolide derivative and analogue and an application to the treatment, the prevention and the relief on human viruses and ne...  
WO/2013/191943
A process for purifying a crude furan 2,5-dicarboxylic acid composition (cFDCA) by hydrogenation of a FDCA composition dissolved in a hydrogenation solvent such as water, and hydrogenating under mild conditions, such as at a temperature ...  
WO/2013/191942
A process to produce a purified dimethyl-furan-2,5-dicarboxylate (DMFD) by feeding furan dicarboxylic acid and methanol to an esterification zone to generate a crude diester composition, and purifying the crude diester composition with a...  
WO/2013/190482
The present invention relates to a compound of formula (I): in which: Rdenotes a hydrogen atom or an acetyl group; and Ydenotes a radical chosen from OR' or NAR''; and their salts, their solvates and their optical isomers, their racemate...  
WO/2013/191938
A process for the manufacture of dialkyl furan-2,5-dicarboxylate (DAFD) vapor composition by feeding furan-2,5-dicarboxylic acid ("FDCA") to an esterification reactor and in the presence of an alcohol compound such as methanol, conductin...  
WO/2013/186550
A compound of formula (I): (I) wherein Y is, Z is OR10, NR11R11 SR11, S(0)R11 S02R11, R10 is H, optionally substituted alkyl, optionally substituted cycloalkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally s...  
WO/2013/186203
A method of modifying the taste of a consumable, comprising adding to a consumable base at least one compound of the formula I in which (a) A is selected from the moieties (i) or (ii); (b) n is from 0-7, such that X is absent or a linear...  
WO/2013/188252
The diallyl ether derivatives of the cis and trans stereoisomers of 2,5-bis(hydroxymethyl)tetrahydrofuran are produced. These materials are expected to be useful for making a variety of biobased polymers. Processes are further described ...  
WO/2013/188480
Disclosed is a process to prepare a ribonolactone compound of Formula (I):[PLEASE INSERT CHEMICAL STRUCTURE HERE] comprising the step of reacting a fructosamine compound of Formula (II):[PLEASE INSERT CHEMICAL STRUCTURE HERE] in the pres...  
WO/2013/188252
The diallyl ether derivatives of the cis and trans stereoisomers of 2,5-bis(hydroxymethyl)tetrahydrofuran are produced. These materials are expected to be useful for making a variety of biobased polymers. Processes are further described ...  
WO/2013/185435
The present invention relates to an optical activity axially chiral α-allenic alcohol, a synthesis method and use thereof. A method of preparing a high optical activity chiral α-allenic alcohol by using propargyl alcohol, aldehyde and ...  
WO/2013/186203
A method of modifying the taste of a consumable, comprising adding to a consumable base at least one compound of the formula I in which (a) A is selected from the moieties (i) or (ii); (b) n is from 0-7, such that X is absent or a linear...  
WO/2013/182263
The invention relates to specific phenanthrenes, the use of the compound in an electronic device, and an electronic device containing at least one of said compounds. The invention further relates to a method for producing the compound an...  
WO/2013/184202
The present application discloses benzathine and related compounds and their use as FBXO-3 inhibitors.  
WO/2013/183380
The present invention relates to: provision of a method for producing an acrylic polymerizable monomer that can be used in various applications such as optical materials, resist materials, coating materials and lamination materials; and ...  
WO/2013/182046
An organic electronic material having the structure of formula (I) or (II) as described below and an organic electroluminescent device are disclosed. The organic electroluminescent device possesses high electronic transmission and inject...  
WO/2013/181786
Provided in the present invention are various labdane diterpenoid compounds and derivatives thereof for use in preparation of a pharmaceutical composition for preventing or treating neurodegenerative diseases. Also provided in the presen...  
WO/2013/178337
The invention relates to a novel process for the preparation of dronedarone (I) and pharmaceutically acceptable salts thereof, which comprises reacting of compound of formula (IV) with compound of formula (VI) in a Grignard reaction, and...  
WO/2013/179309
The present invention relates to a new series of chemical compounds with a novel norneolignan skeleton (chemical formula I) possessing a biological activity on the central nervous system (CNS), especially memory-enhancing and acetylcholi...  
WO/2013/180140
The present invention provides a novel dihydroorotic acid dehydrogenase inhibitor that is applicable to various diseases. As an active ingredient, a compound represented by formula (I) (wherein X represents a halogen atom; R1 represents ...  
WO/2013/175746
An organic electroluminescent element wherein between an opposing anode and cathode there is at least an organic light emission layer and an electron transport layer that are adjacent in this order from the anode side, the organic light ...  
WO/2013/177224
The invention provides novel compounds having the general formula (I) and pharmaceutically acceptable salts thereof, wherein the variables RA, subscript n, ring A, X2, L, subscript m, X1, B, R1, R2, R3, R4, R5 and RN have the meaning as ...  
WO/2013/174925
PATENT APPLICATION. TITLE: NEW STRIGOLACTONE ANALOGUES AND THE USE THEREOF FOR THE TREATMENT OF PLANTS. ABSTRACT: The invention concerns a compound with the general formula (I): (I) in which X represents O, S, NH or an N-alkyl radical, R...  
WO/2013/175211
The present invention relates to the prophylaxis of acute noise- induced hearing loss by administering a compound of formula (I): wherein: W is group (Wa), group (Wb) or group (Wc):  
WO/2013/177243
A process for making the compound of Formula I utilizes the starting compound, together with sulfilimine and sulfoxide process steps later on.  
WO/2013/170694
The present invention relates to a compound as represented by formula (I), pharmaceutical composition thereof as well as preparation method and uses thereof, in particular to the uses of the compound as represented by formula (I) for tre...  
WO/2013/172239
The present invention is an acid diffusion control agent consisting of at least one compound selected from among the group consisting of a compound represented by formula (1) and a compound represented by formula (2). In formula (1), R2 ...  
WO/2013/171332
The present invention relates to tertiary amines of formula (I) for use in therapy, particularly for use in treating cardiovascular disorders. The compounds have been found to regulate phospholamban phosphorylation by interfering with th...  
WO/2013/168048
Phenacene compounds of formula (I) are disclosed. All the variables in the formula are the same as defined in the description. A thin film semiconductor comprising the above compounds, and a field effect transistor device, a photovoltaic...  
WO/2013/169651
A method of making an anti-Markovnikov addition product is carried out by reacting an acid with an alkene or alkyne in a dual catalyst reaction system to the exclusion of oxygen to produce said anti-Markovnikov addition product; the dual...  
WO/2013/169651
A method of making an anti-Markovnikov addition product is carried out by reacting an acid with an alkene or alkyne in a dual catalyst reaction system to the exclusion of oxygen to produce said anti-Markovnikov addition product; the dual...  
WO/2013/166618
The present invention discloses use of prodrug of 4,9-dihydroxy-naphtho[2,3-b]furan derivative for circumventing cancer multidrug resistance. The present invention also discloses use of prodrug of 4,9-dihydroxy-naphtho[2,3-b]furan deriva...  
WO/2013/164292
The present invention relates to compounds of general formula (I), wherein the groups R1, R2 and m are defined as in claim 1, which have valuable pharmacological properties, in particular bind to the GPR40 receptor and modulate its activ...  
WO/2013/164729
Provided herein is an improved, commercially viable and industrially advantageous process for the preparation of a prostaglandin derivatives and intermediates thereof, in high yield and purity.  
WO/2013/158251
The invention relates to fluorinated compounds and their use in the field of pathological syndromes of the cardiovascular system. Novel fluorinated benzofuran derivatives of amiodarone and pharmaceutically acceptable salts or solvates th...  
WO/2013/156398
The present invention relates to novel processes for improved preparation of homofarnesol, especially of (3E,7E)-homofarnesol and homofarnesol preparations having an elevated content of (3E,7E)-homofarnesol (also referred to as all-E-hom...  
WO/2013/157528
Provided is a medicinal agent comprising a compound represented by general formula (1), a pharmaceutically acceptable salt of the compound or a solvate of the compound or the pharmaceutically acceptable salt. A compound represented by ge...  
WO/2013/156738
Lichesterinic acid and the derivatives of same as pigmentation inhibitors. The invention relates to the cosmetic use of a compound chosen from the compounds of formula (A) and the salts of same as an agent for depigmenting the skin and/o...  
WO/2013/156200
A process for obtaining (ethyne-1,2-diyl)bis(isobenzofuran-1,3-dione) is disclosed. In the disclosed process chloro-, bromo-, or iodoisobenzofuran-1,3-dione is reacted with ethyne in a solvent in the presence of a dissolved homogenous pa...  
WO/2013/156738
Lichesterinic acid and the derivatives of same as pigmentation inhibitors. The invention relates to the cosmetic use of a compound chosen from the compounds of formula (A) and the salts of same as an agent for depigmenting the skin and/o...  
WO/2013/152963
The invention relates to a polycondensation product comprising, as monomer components, at least one aryl polyoxyalkylene ether, at least one vicinally disubstituted aromatic compound, at least one aldehyde, and optionally further aromati...  
WO/2013/144098
The present invention relates to compounds of general formula (I), wherein the groups R1, R2 and m are defined as in claim 1, which have valuable pharmacological properties, in particular bind to the GPR40 receptor and modulate its activ...  
WO/2013/144931
The T cells specific to human collagen type II, one of the possible autoantigens, have a crucial role in the development of rheumatoid arthritis in the context of HLA-DR4. The protein-protein interactions between the T cell receptor (TCR...  
WO/2013/146943
An arctigenin derivative is created and used for anti-aging treatment, including in order to protect skin from the sun and to recover skin elasticity. A variety of fatty acid ester derivatives, alcohol ether derivatives and alkylated der...  
WO/2013/146437
[Problem] To provide a novel compound that is useful as an agent for preventing/treating cancer. [Solution] One aspect of the present invention provides a compound expressed by the chemical formula (1) or a pharmaceutically permissible s...  
WO/2013/148255
Compositions containing tetrahydrofurfuryl and/or alkyl-substituted tetrahydrofurfuryl esters of citric acid are provided. These esters of citric acid can be formed from renewable materials and can be used, for example, as plasticizers f...  
WO/2013/142999
Disclosed is a compound of formula (1), or a pharmaceutically acceptable salt thereof, where R1, R2, R3, R4, R5, R6, R7, R7', R8, R9, R10, R11, R12 and R13 are as disclosed herein. Also, disclosed is a process for the preparation of the ...  
WO/2013/148923
Provided are catalysts suitable for the production of tetrahydrofuran from 1,4- butanediol. Also provided are methods of use of these catalyst, as well as catalyst systems. The catalysts described herein contain only Lewis acidity, but n...  
WO/2013/146085
The present invention relates to: a method for producing 5-hydroxymethyl furfural (HMF), which comprises the steps a-c described below; and a method for producing 5-hydroxymethyl furfural oxide, which comprises the steps a-d described be...  
WO/2013/148620
The disclosure provides compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected w...  

Matches 151 - 200 out of 14,060